Digital Pharma: Pfizer launches European YouTube channel
pharmafile | December 2, 2009 | Feature | Medical Communications, Sales and Marketing | Pfizer, digi, digital pharma, youtube
Pfizer has set up a YouTube channel to promote its European operations by showcasing some of its people.
In one sequence of three videos we Regional President of European Specialty Care Cees Heiman having breakfast, driving to work and walking into his office, all the while talking about Pfizer, its work and motivations.
“No party alone can solve today’s staggering healthcare burden on people and economies,” says Heiman: “We really all need to work together.”
In another video Heiman notes: “Pfizer invests more in research than any other bio-pharmaceutical company. We have the brilliant scientists, and the capabilities and facilities it takes to discover the new molecules of the future, the new molecules that will address unmet medical needs.”
The company has so far uploaded ten videos to the channel, which also feature employees from Belgium, the UK, Spain, Greece, Finland, Hungary and Norway.
They talk about how proud they are to work for the company, what a difference it makes to people’s lives and finishing on a fact about their family or hobby.
For example, there’s Ludwig from Belgium, who “works to discover and develop more effective cancer medications and on improving his indoor soccer results”.
Christine Dunai, the company’s manager of global corporate media relations for Europe, explained the rationale behind the project: “The specific aim of this European YouTube channel is to make available some of the interesting aspects of Pfizer’s work, our people, commitments and activities to a wider Europe public.
“To date, the Pfizer Europe YouTube channel features videos of Pfizer employees from across Europe, who talk about their work and responsibilities and also open up their personal lives a bit – demonstrating what interesting backgrounds, commitment, dedication and passions can typically be found in Pfizer’s people.”
The videos will have some way to go to match the interest generated by the company’s ‘dead rat‘ anti-counterfeiting ad.
The ad is the only video on Pfizer UK’s YouTube channel and has been viewed nearly 20,000 times since it was uploaded at the end of October.
Dominic Tyer is web editor for Pharmafocus and InPharm.com and the author of the Digital Pharma blog. He can be contacted via email, Twitter or LinkedIn.
Related Content
NHS accepts Pfizer’s tafamidis for ATTR-CM treatment
NHS England has announced that it has accepted Pfizer’s drug, tafamidis, for the treatment of …
Pfizer’s Beqvez approved by FDA for haemophilia B treatment
Pfizer has announced that the US Food and Drug Administration (FDA) has approved Beqvez (fidanacogene …
EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment
Pfizer has announced that the European Commission (EC) has granted marketing authorisation for Emblaveo (aztreonam-avibactam) …
